Mediwatch Share Discussion Threads

[yump] 18/11/2013 07:32

Given that it was 9p last back in 2010, I'd guess there are a lot of investors who are quite happy to have 6p, given that its twice what the share price has been for the last 3 years. So that's anyone that bought since 2010 + anyone who averaged down in that 3years and ended up with an average below 6p.

In practice, whether its a fair price or not is a bit academic.

[p1nkfish] 18/11/2013 07:30

trout, NOT SHAREHOLDERS, the company management has neglected promotion of the company to INVESTORS. Another example of poor management. Add it to the list, it was only getting better when they signed Harrison, slowly. The outcome does not surprise me. I thought 8p would be a stretch.

CEO has taken care of himself. Surprise, surprise. It has been run more like that than for others for years.

Well, 6p will have to do.

[leedslad001] 18/11/2013 07:28

Lets now see what the other companies think we are worth! let the others now top this poor offer

[troutisout] 18/11/2013 07:18

PS has sold us out and managed to get himself sorted on a new contract with laborie.

Note how this deal will be good for customers and employees of Mediwatch but not the shareholders. Unfortunately the low share price allowed this to happen and shareholders did not help support this , some have and will get out with a profit, but it should have been more!

The way it has been set up sounds like they know they are going to get many not accepting, there is also a sting about the Directors 27% being irrevocable, even if a third party offer comes in that is higher.

Still can't understand while some hadn't been buying in the last 4 weeks, an opportunity missed.

Let's see what happens,

Trout.

[leedslad001] 18/11/2013 07:10

Not good price
What are we going to do now?

[troutisout] 18/11/2013 07:06

There you go......6p

[p1nkfish] 17/11/2013 21:55

barry, Mediwatch will soon become even more dependent on PSAWatch finally getting approvals and starting to ship as they get their lunch eaten in other areas. If PSAWatch approvals are likely for the US/China then a 1-2 yr wait would be well worth it and they would be silly to endorse any Laborie offer.

Laborie are entitled to table an offer no matter what the BoD may think of it if they are prepared to swallow the cost of approaching the shareholder base. The BoD are then entitled to give their opinion of the offer and a recommendation, and that of their adviser, for the shareholder base to consider.

So, will PSAWatch deliver FDA and/or SFDA in 1-2 years? I have no idea given the track record.

If it doesn't achieve the approvals then selling now will save wasting more time and money. So far, Mediwatch have failed to manage increased shareholder value over many years. This might be a convenient exit. 8p would be OK with me and mine, cash, at this moment.

Mediwatch management have also failed to ever give realistic timescales for PSAWatch FDA approvals. Will they be able to say to the shareholders they will have it done within 2 yrs? If so, can't they do the same to Laborie now too and have some of the increased company value accounted for in any offer?

[troutisout] 17/11/2013 21:00

Dorset, nothing pointless about my post thank you, it is entirely possible that negotiations carried on into Friday night and throughout the weekend, therefore it is entirely possible that we get a 7am RNS tomorrow.

The rest about Medica is very relevant too.

[barrywhit] 17/11/2013 20:44

Dorset,

Being selfish I hope MDW do blow them out, any offer in single digits I would vote against....I would want MDW to go another 1 - 2 years even if they needed to raise a bit of finance via a small placing..

[dorset64] 17/11/2013 20:09

troutisout 17 Nov'13 - 19:34 - 31863 of 31864 0 0

Hi all,
Just a look in here, they haven't granted an extra day, they have given them an extra weekend and working day. I don't think they would have stopped negotiations because it is the weekend, so it is quite possible we see a 7am RNS.
--------------------------------------------------

troutie, pointless post as you know, like everyone else exactly what was meant. Negotiations had to stop on Friday, read the RNS, hence the extra day.

Barry, you are correct of course but it would had been lab not MDW asking for the extra day, so they must be nearly there with an answer I would guess. As abergele says it could just be the paperwork including the clauses that they have to agree.

I couldn't see MDW granting anymore time if 1, if Lab had not given the impression that they were about to make an offer and 2, if the negotiations to date were not amicable. I was recently approached and I too afforded the suitors more time after initial negotiations and, although the $ offer was great, I walked away as the make up of the deal itself was not right at all. They have since re-approached but I declined as the same clauses were still in place, albeit with a slightly higher price.

After all this MDW may still blow them out of the water if the price isn't right for them, not forgetting shareholders and to most onlookers this should be seen as MDW being in a strong position going forward, but I doubt the markets would see it that way & would hit the share price

[abergele] 17/11/2013 19:51

Good evening Troutie,
Just a thought,
If between 4 and 5pm last friday they had a verbal agreement,
that ethically would'nt have been pos. to put out an rns until it was a written thing,black and white,so no if's and but's.

Could this not have been the proper way rather than a handshake and a thanks very much.
If that was the case,and now all written up for the signatures,after burning the midnight oil, an early monday rns may be pos. as someone said before

[troutisout] 17/11/2013 19:34

Hi all,
Just a look in here, they haven't granted an extra day, they have given them an extra weekend and working day. I don't think they would have stopped negotiations because it is the weekend, so it is quite possible we see a 7am RNS.

A couple of other things, it is Medica this week and Laborie are exhibiting and launching new products, in attendance will be Ray Laborie and Rob Laborie.
So are they over here and moving onto Germany this week?



Secondly on that note, would they want to go into one of the World's largest medical trade fairs having not managed to get Mediwatch? Would that leave them with a little egg on their face?

Trout.

[barrywhit] 17/11/2013 19:24

Evening All,

Dorset, I'm sure they are close to making an offer..

"Discussions are at an advanced stage but there is no certainty that at the end of this period, an offer for Mediwatch will be made.

A further announcement will be made in due course".

[optomistic] 17/11/2013 14:34

Yes Dorset I agree in that they must be pretty close with the figures, I just hope that our directors have been firm in their negotiations.

[dorset64] 17/11/2013 13:53

I'm guessing they must be close to offering a deal as what is the point of only a day or so extension. If they were still miles apart MDW would had surely told them to sling their hook but, as the RNS states, they have an extra day to agree things in principle in the Lab house before they offer a price.

[optomistic] 17/11/2013 12:45

7.5p would just get me to break even...held for 9yrs!
Even now 7.5p is still up in the sky, how many are looking for double figures for break even?...miracles can still happen I guess like another predator showing its face at the last minute.

[dorset64] 17/11/2013 11:00

leeds, not sure if they would openly offer 12p when the share price was in the region of 2.5p+ when they approached. My guess and thats all it could be is for an offer in the region of 6-7p max, what MDW have to hold out for is a figure above this to take account of cost savings, new products, tax off-sets and licences across the world.

So will they make an offer of circa 3x the price of when they approached.

[p1nkfish] 16/11/2013 15:47

What would happen if they don't offer but the outcome was a joint venture of some type? MDW remain independent.

[p1nkfish] 16/11/2013 15:12

'The offeree company must appoint a competent independent adviser whose advice on the offer must be made known to all the shareholders, together with the opinion of the board.'

Above is if an offer is made. It means nothing if most say no and they have to go to the market to buy 30%.

27.5% not in public hands.
What price could they pick-up 30% in the market for?

Laborie could spend a lot of money on taking care of this and still fail if they don't get it right.

If share price Angel are the advisor it looks like one of their biggest if it goes through much more than about £5M.

hxxp://www.thetakeoverpanel.org.uk/the-code/download-code

[barrywhit] 16/11/2013 11:57

Morning Leeds,

That values the company @ £17.2million (1.7 x turnover)...about right, but not sure if we will get any where near that, here's hoping.....

[leedslad001] 16/11/2013 11:23

Morning all
My money is still on 12p offer to stand any chance!

[totally banjo] 16/11/2013 10:45

Laborie are certainly pushing themselves forward in the Urology sector:

LABORIE INTRODUCES NEXT GENERATION MODULAR URODYNAMICS SYSTEM AT MEDICA 2013

15/11/2013
LABORIE

MISSISSAUGA, Ontario, Nov. 6, 2013 – LABORIE, a leading Canadian manufacturer of diagnostic and treatment devices for pelvic floor dysfunction, returns to MEDICA, the world's largest annual medical trade fair, November 20-23 in Düsseldorf, Germany where it will introduce its next generation modular (NGM) Aquarius urodynamics wireless platform.

"Thanks in part to our presence at MEDICA and at numerous other industry trade shows and conferences we attend around the world, we've seen a need for a lot of improvements in urodynamic testing over the years. But rather than try to improve our own product incrementally, we decided to take a fresh-sheet approach and design a brand-new, more adaptable platform," says Mr. Ing Goping, LABORIE Chief Scientific Officer. "As a result, the modular concepts we have embodied in our new Aquarius platform and its family of products (XT/CT/LT) should be particularly suited to our mid- to high-end clients such as larger office, hospital, and university research institutions – centres that typically see a much higher volume of patients than our smaller office clients."

Specifically, Mr. Goping goes on to explain, with the new Aquarius wireless (Bluetooth) technology, users will be able to study bladder outlet obstruction issues and incontinence in more efficient ways.

"Aquarius enables them to do provocative testing with fewer cables and other physical impediments that constrain their patients when using traditional technologies," says Mr. Goping. "Users in large centres will enjoy many of our Goby urodynamics system advantages. But with the new Aquarius's enhanced video image integration options, they will have all the benefits of a comprehensive diagnostic suite".

Mr. Goping also points to another benefit of the new Aquarius being modular: with additional sensor and input options, researchers can use the Aquarius platform to explore new scientific studies without compromising the system's daily clinical needs.

LABORIE has kept many of the best design elements of previous Aquarius iterations; but has added new ergonomic elements to the latest NGM Aquarius version, based on market feedback and extensive time and motion studies conducted in real world settings.

Initially presented at both North American and European scientific national conferences, LABORIE officials report that both loyal and first-time users have received the new Aquarius and its innovative modularity extremely well.

"Innovation, whether to improve clients' efficacy or to address their ever-burdening cost-containment issues, will always be a primary focus for us," says CSO Goping. "LABORIE constantly improves and enhances all its system offerings and the new Aquarius is no exception."


About LABORIE.


LABORIE is a leading multinational developer, manufacturer and marketer of innovative medical equipment and catheters in urology and gynecology for the diagnosis and treatment of incontinence, bladder outlet obstruction, and other pelvic floor dysfunction.

For more information regarding LABORIE's complete line of products and partnership, please come see us at MEDICA 2013 in Hall 16, Booth G42.

[troutisout] 16/11/2013 01:37

Let's hope you get a little more than that Barry!

Off to bed now, busy day ahead, somehow managed to get myself embroiled into a meal and a matinee in the West End with the family, when England and New Zealand will be battling it out at HQ.

Should have done my own research!

Trout.

[barrywhit] 16/11/2013 01:30

Just got back from a charity evening Trout ,alas i think you are correct..i have a feeling I have invested for 10 years just to hopefully get my money back...